Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Process Hepatitis B Vaccine in Healthy Neonates
NCT00322361Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2006
- Primary completion
- Jul 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 2 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Merck & Co.. Started May 2006; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00322361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322361.